XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues $ 54,471 $ 34,004 $ 94,761 $ 64,258
Cost of revenues 38,858 25,418 66,923 49,390
Gross margin 15,613 8,586 27,838 14,868
Operating expenses:        
Research and development 2,646 1,641 4,931 3,493
Selling, general and administrative 10,525 7,946 19,423 15,815
Amortization of acquisition-related intangibles 433 538 845 1,076
Change in fair value of contingent consideration 2,762 850 6,682 2,200
Restructuring 0 (20) 0 (14)
Total operating expenses 16,366 10,955 31,881 22,570
Operating loss (753) (2,369) (4,043) (7,702)
Interest income, net 979 194 2,099 368
Other expense, net (329) (204) (489) (321)
Loss before income tax expense (benefit) (103) (2,379) (2,433) (7,655)
Income tax (benefit) expense (4,990) 106 (4,796) 228
Net income (loss) $ 4,887 $ (2,485) $ 2,363 $ (7,883)
Net income (loss) per common share        
Basic (in dollars per share) $ 0.13 $ (0.09) $ 0.07 $ (0.28)
Diluted (in dollars per share) $ 0.13 $ (0.09) $ 0.06 $ (0.28)
Weighted average number of common shares outstanding        
Basic (in shares) 36,952 28,828 36,317 28,545
Diluted (in shares) 37,499 28,828 36,951 28,545